<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04091841</url>
  </required_header>
  <id_info>
    <org_study_id>1398/022</org_study_id>
    <nct_id>NCT04091841</nct_id>
  </id_info>
  <brief_title>Trial of Protein Supplement on Vertebral Fusion in Posterior Spine Fusion Surgery</brief_title>
  <official_title>The Effect of Protein Supplement on Vertebral Fusion and Enhanced Recovery After Posterior Spine Fusion Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Receiving protein can affect the bone formation and maintenance by providing a structural
      matrix of the bone, optimizing the level of IGF-1, increasing intestinal calcium absorption,
      transferring phosphorous, and improving muscle strength.Therefore, protein may be effective
      on vertebral fusion by such mechanisms. In this trial patients undergoing elective posterior
      spine fusion surgery are divided into two groups of intervention or control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double blind, controlled trial will be conducted in patients undergoing
      elective posterior spine fusion surgery in Tehran, Iran. After a full review of the inclusion
      and exclusion criteria and explanation of the risks and benefits of the study, written
      consent form will be completed. The participants are 60 eligible posterior spine fusion
      surgery patients, aged â‰¥ 18 years. Intervention patients will be received 36 grams of protein
      supplement along with diet containing 1.2 g/kg/day of protein for 30 days after surgery and
      control patients will be received maltodextrin along with diet containing 1.2 g/kg/day of
      protein 30 days after surgery. Patients will be evaluated for occurrence of vertebral fusion
      and enhanced recovery after 3 months surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Actual">May 1, 2020</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of vertebral fusion in CT scan</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Rate of formation of a solid bony Union in CT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of wound healing</measure>
    <time_frame>48 hour, 10 days and 1 month after surgery</time_frame>
    <description>Rate of wound healing, the sutures of the surgery, inspected by granulation tissue formation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of of wound infection</measure>
    <time_frame>48 hour and 10 days after surgery</time_frame>
    <description>Rate of of wound infection, revealed by physical examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of pre and postoperative pain</measure>
    <time_frame>baseline, 48 hour, 10 days 1 and 3 month after surgery</time_frame>
    <description>pain measured by the visual analogue scale or visual analog scale (VAS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of serum IGF-1</measure>
    <time_frame>baseline, 1 month after surgery</time_frame>
    <description>Concentration of Insulin-like growth factor-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of serum albumin</measure>
    <time_frame>baseline, 1 month after surgery</time_frame>
    <description>Concentration of serum albumin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of serum total protein</measure>
    <time_frame>baseline, 1 month after surgery</time_frame>
    <description>Concentration of serum total protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of serum hsCRP</measure>
    <time_frame>baseline, 10 days after the surgery</time_frame>
    <description>Concentration of serum high-sensitivity C-reactive protein</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Spine Surgery</condition>
  <arm_group>
    <arm_group_label>protein supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention patients will be received protein diet (1.2 g/kg/day) and protein supplement (36 g/day) for 1 month after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>maltodextrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control patients will be received protein diet (1.2 g/kg/day) and maltodextrin for 1 month after surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>protein supplement</intervention_name>
    <description>Three sachet of protein supplement to be mixed in with water used daily.</description>
    <arm_group_label>protein supplement</arm_group_label>
    <other_name>Pure-protein</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Maltodextrine</intervention_name>
    <description>Three sachet of Maltodextrine supplement to be mixed in with water used daily.</description>
    <arm_group_label>maltodextrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Adult patients 18-65 years

          -  Body mass index 18.5-30

          -  Candidate for the elective posterior spine fusion

          -  Without history of severe liver disorder

          -  Without history of Kidney disorder

          -  Without history of diabetes

          -  Without history of trauma and fracture of the vertebral

          -  Without history of osteoporosis

          -  Without history of Gastrointestinal malabsorption

          -  Without history of Parathyroid gland disorders

          -  Without taking medications that affect the metabolism of bone, such as calcitonin,

          -  bisphosphonate, corticosteroid

          -  No smoking

        Exclusion Criteria:

          -  Allergy or intolerance to protein or maltodextrine supplement

          -  Unwillingness to continue cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zahra vahdat shariatpanahi, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Nutrition and Food Technology, SBMU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zahra vahdat shariatpanahi</name>
      <address>
        <city>Tehran</city>
        <zip>+98</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 5, 2019</study_first_submitted>
  <study_first_submitted_qc>September 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>Zahra Vahdat Shariatpanahi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Protein supplement</keyword>
  <keyword>Protein diet</keyword>
  <keyword>Vertebral fusion</keyword>
  <keyword>Enhanced recovery after surgery</keyword>
  <keyword>Infection</keyword>
  <keyword>Wound healing</keyword>
  <keyword>Pain</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

